DrugPatentWatch Database Preview
Details for Patent: 7,163,931
» See Plans and Pricing
Which drugs does patent 7,163,931 protect, and when does it expire?
Patent 7,163,931 protects BEYAZ, SAFYRAL, and YAZ, and is included in three NDAs.
This patent has seventy-three patent family members in thirty-eight countries.
Summary for Patent: 7,163,931
| Title: | Compositions of estrogen-cyclodextrin complexes |
| Abstract: | Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition comprises a complex between ethinyl estradiol and .beta.-cyclodextrin in a granulate preparation and in yet another embodiment the composition comprises a limited amount of polyvinylpyrrolidone since this excipient was found to degrade ethinyl estradiol. Furthermore, a method for improving the stability of an estrogen in a composition and for manufacturing such a stable composition is provided. Essentially, the granulate preparation are manufactured under careful control of the relative humidity. |
| Inventor(s): | Backensfeld; Thomas (Berlin, DE), Heil; Wolfgang (Berlin, DE), Lipp; Ralph (Berlin, DE) |
| Assignee: | Schering Aktiengesellchaft (Berlin, DE) |
| Application Number: | 11/102,681 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,163,931 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 7,163,931
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | BEYAZ | drospirenone; ethinyl estradiol; levomefolate calcium | TABLET;ORAL | 022532-001 | Sep 24, 2010 | AB | RX | No | No | Start Trial | Start Trial | PREVENTION OF PREGNANCY | Start Trial | |||
| Bayer Hlthcare | SAFYRAL | drospirenone; ethinyl estradiol; levomefolate calcium | TABLET;ORAL | 022574-001 | Dec 16, 2010 | AB | RX | Yes | Yes | Start Trial | Start Trial | PREVENTION OF PREGNANCY | Start Trial | |||
| Bayer Hlthcare | YAZ | drospirenone; ethinyl estradiol | TABLET;ORAL | 021676-001 | Mar 16, 2006 | AB | RX | Yes | Yes | Start Trial | Start Trial | PREVENTION OF PREGNANCY | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,163,931
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 00610135 | Dec 20, 2000 | |
International Family Members for US Patent 7,163,931
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 032205 | Start Trial | |||
| Austria | 311204 | Start Trial | |||
| Australia | 1941802 | Start Trial | |||
| Australia | 2002219418 | Start Trial | |||
| Australia | 2006225232 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
